Correlation Between Verona Pharma and BioLineRx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Verona Pharma and BioLineRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verona Pharma and BioLineRx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verona Pharma PLC and BioLineRx, you can compare the effects of market volatilities on Verona Pharma and BioLineRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verona Pharma with a short position of BioLineRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verona Pharma and BioLineRx.

Diversification Opportunities for Verona Pharma and BioLineRx

-0.84
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Verona and BioLineRx is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Verona Pharma PLC and BioLineRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioLineRx and Verona Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verona Pharma PLC are associated (or correlated) with BioLineRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioLineRx has no effect on the direction of Verona Pharma i.e., Verona Pharma and BioLineRx go up and down completely randomly.

Pair Corralation between Verona Pharma and BioLineRx

Given the investment horizon of 90 days Verona Pharma PLC is expected to generate 0.52 times more return on investment than BioLineRx. However, Verona Pharma PLC is 1.91 times less risky than BioLineRx. It trades about 0.15 of its potential returns per unit of risk. BioLineRx is currently generating about -0.11 per unit of risk. If you would invest  1,719  in Verona Pharma PLC on November 2, 2024 and sell it today you would earn a total of  4,011  from holding Verona Pharma PLC or generate 233.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Verona Pharma PLC  vs.  BioLineRx

 Performance 
       Timeline  
Verona Pharma PLC 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Verona Pharma PLC are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Verona Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.
BioLineRx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioLineRx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Verona Pharma and BioLineRx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Verona Pharma and BioLineRx

The main advantage of trading using opposite Verona Pharma and BioLineRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verona Pharma position performs unexpectedly, BioLineRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLineRx will offset losses from the drop in BioLineRx's long position.
The idea behind Verona Pharma PLC and BioLineRx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios